News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael T. Eaddy, PharmD, PhD

Articles by Michael T. Eaddy, PharmD, PhD

Cost Comparison of Finasteride and Dutasteride for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

ByMichael Naslund, MD, MBA,Michael T. Eaddy, PharmD, PhD,Eric J. Kruep, PharmD, MS,Susan L. Hogue, PharmD, MPH

May 1st 2008

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

ByMuta M. Issa, MD, MBA,Pei-Jung Lin, PhD,Michael T. Eaddy, PharmD, PhD,Manan B. Shah, PharmD, PhD,E. Anne Davis, PharmD, MS

May 1st 2008

Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

ByMichael James Naslund, MD, MBA,Muta M. Issa, MD, MBA,Amy L. Grogg, PharmD,Michael T. Eaddy, PharmD, PhD,Libby Black, PharmD

March 1st 2006

The Cost of Treating the 10 Most Prevalent Diseases in Men 50 Years of Age and Older

ByThomas C. Fenter, MD,Michael James Naslund, MD, MBA,Manan B. Shah, PharmD, PhD,Michael T. Eaddy, PharmD, PhD,Libby Black, PharmD

March 1st 2006

The Hidden Condition: Status, Challenges, and Opportunities in the Management of Enlarged Prostate for Managed Care

ByMichael James Naslund, MD, MBA,Evelyn Chiao, PharmD,Libby Black, PharmD,Michael T. Eaddy, PharmD, PhD

March 1st 2006

Adherence to Paroxetine CR Compared With Paroxetine IR in a Medicare-eligible Population With Anxiety Disorders

ByMatthew S. Keene, MD,Michael T. Eaddy, PharmD, PhD,Winnie W. Nelson, PharmD, MS,Matthew W. Sarnes, PharmD

October 20th 2005

Differences in Total Medical Costs Across the SSRIs for the Treatment of Depression and Anxiety

ByDavid V. Sheehan, MD, MBA,Michael T. Eaddy, PharmD, PhD,Manan B. Shah, PharmD, PhD,Robert P. Mauch, Jr, PharmD, PhD

October 20th 2005

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access